tiprankstipranks
Trending News
More News >
Amicus Therapeutics (FOLD)
:FOLD
US Market
Advertisement

Amicus (FOLD) Technical Analysis

Compare
1,026 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Amicus Therapeutics’s (FOLD) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Amicus Therapeutics is a Sell.
Amicus Therapeutics’s (FOLD) 20-Day exponential moving average is 6.12, while Amicus Therapeutics’s (FOLD) share price is $6.28, making it a Buy.
Amicus Therapeutics’s (FOLD) 50-Day exponential moving average is 6.27, while Amicus Therapeutics’s (FOLD) share price is $6.28, making it a Buy.

Amicus (FOLD) Pivot Points

Jul 26, 2025, 04:54 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.97
6.06
6.19
6.28
6.40
6.49
6.62
Fibonacci
6.06
6.15
6.20
6.28
6.36
6.41
6.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amicus (FOLD) Moving Averages

Jul 26, 2025, 04:54 AM
Period
Simple
Exponential
MA5
6.16Buy
6.22Buy
MA10
6.14Buy
6.17Buy
MA20
6.08Buy
6.12Buy
MA50
6.08Buy
6.27Buy
MA100
6.90Sell
6.92Sell
MA200
8.47Sell
8.29Sell
Amicus Therapeutics’s (FOLD) 10-Day exponential moving average is 6.17, while Amicus Therapeutics’s (FOLD) share price is $6.28, making it a Buy.
Amicus Therapeutics’s (FOLD) 100-Day exponential moving average is 6.92, while Amicus Therapeutics’s (FOLD) share price is $6.28, making it a Sell.
Amicus Therapeutics’s (FOLD) stock price is $6.28 and Amicus Therapeutics’s (FOLD) 50-day simple moving average is 6.08, creating a Buy signal.
Amicus Therapeutics’s (FOLD) stock price is $6.28 and Amicus Therapeutics’s (FOLD) 100-day simple moving average is 6.90, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $6.28 and Amicus Therapeutics’s (FOLD) 200-day simple moving average is 8.47, creating a Sell signal.

Amicus (FOLD) Technical Indicators

Jul 26, 2025, 04:54 AM
Name
Value
Implied Action
RSI (14)
54.36
Neutral
STOCH (9,6)
43.82
Neutral
STOCHRSI (14)
45.90
Neutral
MACD (12,26)
0.04
Sell
ADX (14)
18.49
Buy
Williams %R
-55.06
Buy
CCI (14)
84.54
Neutral
ATR (14)
0.25
-
Ultimate Oscillator
45.67
Neutral
ROC
2.95
Buy
Amicus Therapeutics’s (FOLD) Relative Strength Index (RSI) is 54.36, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Trend Strength Indicator (ADX) is 18.49, creating a Buy signal.
Amicus Therapeutics’s (FOLD) Commodity Channel Index (CCI) is 84.54, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Price Rate of Change (ROC) is 2.95, creating a Buy signal.

FAQ

Is FOLD a Buy, Hold, or Sell?
Based on FOLD’s technical indicators, FOLD is a Buy.
    What is FOLD’s RSI (14)?
    FOLD’s RSI (14) is 54.36, which suggests FOLD is a Neutral.
      What is FOLD’s MACD?
      FOLD’s MACD is 0.04, which suggests FOLD is a Sell.
        What is FOLD’s 5-day moving average?
        FOLD’s 5-day moving average is 6.16, which suggests FOLD is a Buy.
          What is FOLD’s 20-day moving average?
          FOLD 20-day moving average is 6.08, which suggests FOLD is a Buy.
            What is FOLD’s 50-day moving average?
            FOLD’s 50-day moving average is 6.08, which suggests FOLD is a Buy.
              What is FOLD’s 200-day moving average?
              FOLD’s 200-day moving average is 8.47, which suggests FOLD is a Sell.
                What is FOLD’s Williams % R (14)?
                FOLD’s Williams % R (14) is -55.06, which suggests FOLD is a Buy.
                  What is FOLD’s CCI (14)?
                  FOLD’s CCI (14) is 84.54, which suggests FOLD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis